Copyright Reports & Markets. All rights reserved.

Global Transcranial Magnetic Stimulation Treatment Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Transcranial Magnetic Stimulation Treatment Market Size 2017-2028
    • 2.1.2 Transcranial Magnetic Stimulation Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Transcranial Magnetic Stimulation Treatment Segment by Type
    • 2.2.1 Deep Transcranial Magnetic Stimulation Treatment
    • 2.2.2 General Transcranial Magnetic Stimulation Treatment
  • 2.3 Transcranial Magnetic Stimulation Treatment Market Size by Type
    • 2.3.1 Transcranial Magnetic Stimulation Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Transcranial Magnetic Stimulation Treatment Market Size Market Share by Type (2017-2022)
  • 2.4 Transcranial Magnetic Stimulation Treatment Segment by Application
    • 2.4.1 Depression
    • 2.4.2 Anxiety Disorder
    • 2.4.3 Obsessive-compulsive Disorder
    • 2.4.4 Smoking Addiction
    • 2.4.5 Other
  • 2.5 Transcranial Magnetic Stimulation Treatment Market Size by Application
    • 2.5.1 Transcranial Magnetic Stimulation Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Transcranial Magnetic Stimulation Treatment Market Size Market Share by Application (2017-2022)

3 Transcranial Magnetic Stimulation Treatment Market Size by Player

  • 3.1 Transcranial Magnetic Stimulation Treatment Market Size Market Share by Players
    • 3.1.1 Global Transcranial Magnetic Stimulation Treatment Revenue by Players (2020-2022)
    • 3.1.2 Global Transcranial Magnetic Stimulation Treatment Revenue Market Share by Players (2020-2022)
  • 3.2 Global Transcranial Magnetic Stimulation Treatment Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Transcranial Magnetic Stimulation Treatment by Regions

  • 4.1 Transcranial Magnetic Stimulation Treatment Market Size by Regions (2017-2022)
  • 4.2 Americas Transcranial Magnetic Stimulation Treatment Market Size Growth (2017-2022)
  • 4.3 APAC Transcranial Magnetic Stimulation Treatment Market Size Growth (2017-2022)
  • 4.4 Europe Transcranial Magnetic Stimulation Treatment Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Transcranial Magnetic Stimulation Treatment Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Transcranial Magnetic Stimulation Treatment Market Size by Country (2017-2022)
  • 5.2 Americas Transcranial Magnetic Stimulation Treatment Market Size by Type (2017-2022)
  • 5.3 Americas Transcranial Magnetic Stimulation Treatment Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Transcranial Magnetic Stimulation Treatment Market Size by Region (2017-2022)
  • 6.2 APAC Transcranial Magnetic Stimulation Treatment Market Size by Type (2017-2022)
  • 6.3 APAC Transcranial Magnetic Stimulation Treatment Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Transcranial Magnetic Stimulation Treatment by Country (2017-2022)
  • 7.2 Europe Transcranial Magnetic Stimulation Treatment Market Size by Type (2017-2022)
  • 7.3 Europe Transcranial Magnetic Stimulation Treatment Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Transcranial Magnetic Stimulation Treatment by Region (2017-2022)
  • 8.2 Middle East & Africa Transcranial Magnetic Stimulation Treatment Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Transcranial Magnetic Stimulation Treatment Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Transcranial Magnetic Stimulation Treatment Market Forecast

  • 10.1 Global Transcranial Magnetic Stimulation Treatment Forecast by Regions (2023-2028)
    • 10.1.1 Global Transcranial Magnetic Stimulation Treatment Forecast by Regions (2023-2028)
    • 10.1.2 Americas Transcranial Magnetic Stimulation Treatment Forecast
    • 10.1.3 APAC Transcranial Magnetic Stimulation Treatment Forecast
    • 10.1.4 Europe Transcranial Magnetic Stimulation Treatment Forecast
    • 10.1.5 Middle East & Africa Transcranial Magnetic Stimulation Treatment Forecast
  • 10.2 Americas Transcranial Magnetic Stimulation Treatment Forecast by Country (2023-2028)
    • 10.2.1 United States Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.2.2 Canada Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.2.3 Mexico Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.2.4 Brazil Transcranial Magnetic Stimulation Treatment Market Forecast
  • 10.3 APAC Transcranial Magnetic Stimulation Treatment Forecast by Region (2023-2028)
    • 10.3.1 China Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.3.2 Japan Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.3.3 Korea Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.3.4 Southeast Asia Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.3.5 India Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.3.6 Australia Transcranial Magnetic Stimulation Treatment Market Forecast
  • 10.4 Europe Transcranial Magnetic Stimulation Treatment Forecast by Country (2023-2028)
    • 10.4.1 Germany Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.4.2 France Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.4.3 UK Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.4.4 Italy Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.4.5 Russia Transcranial Magnetic Stimulation Treatment Market Forecast
  • 10.5 Middle East & Africa Transcranial Magnetic Stimulation Treatment Forecast by Region (2023-2028)
    • 10.5.1 Egypt Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.5.2 South Africa Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.5.3 Israel Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.5.4 Turkey Transcranial Magnetic Stimulation Treatment Market Forecast
    • 10.5.5 GCC Countries Transcranial Magnetic Stimulation Treatment Market Forecast
  • 10.6 Global Transcranial Magnetic Stimulation Treatment Forecast by Type (2023-2028)
  • 10.7 Global Transcranial Magnetic Stimulation Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Mindpath Health
    • 11.1.1 Mindpath Health Company Information
    • 11.1.2 Mindpath Health Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.1.3 Mindpath Health Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Mindpath Health Main Business Overview
    • 11.1.5 Mindpath Health Latest Developments
  • 11.2 Neuronetics
    • 11.2.1 Neuronetics Company Information
    • 11.2.2 Neuronetics Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.2.3 Neuronetics Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Neuronetics Main Business Overview
    • 11.2.5 Neuronetics Latest Developments
  • 11.3 Smart rTMS Limited
    • 11.3.1 Smart rTMS Limited Company Information
    • 11.3.2 Smart rTMS Limited Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.3.3 Smart rTMS Limited Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Smart rTMS Limited Main Business Overview
    • 11.3.5 Smart rTMS Limited Latest Developments
  • 11.4 Magstim
    • 11.4.1 Magstim Company Information
    • 11.4.2 Magstim Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.4.3 Magstim Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Magstim Main Business Overview
    • 11.4.5 Magstim Latest Developments
  • 11.5 MagVenture
    • 11.5.1 MagVenture Company Information
    • 11.5.2 MagVenture Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.5.3 MagVenture Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 MagVenture Main Business Overview
    • 11.5.5 MagVenture Latest Developments
  • 11.6 NeuroStar
    • 11.6.1 NeuroStar Company Information
    • 11.6.2 NeuroStar Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.6.3 NeuroStar Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 NeuroStar Main Business Overview
    • 11.6.5 NeuroStar Latest Developments
  • 11.7 Nexstim
    • 11.7.1 Nexstim Company Information
    • 11.7.2 Nexstim Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.7.3 Nexstim Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Nexstim Main Business Overview
    • 11.7.5 Nexstim Latest Developments
  • 11.8 Neurocare
    • 11.8.1 Neurocare Company Information
    • 11.8.2 Neurocare Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.8.3 Neurocare Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Neurocare Main Business Overview
    • 11.8.5 Neurocare Latest Developments
  • 11.9 Awakenings KC
    • 11.9.1 Awakenings KC Company Information
    • 11.9.2 Awakenings KC Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.9.3 Awakenings KC Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Awakenings KC Main Business Overview
    • 11.9.5 Awakenings KC Latest Developments
  • 11.10 Deymed
    • 11.10.1 Deymed Company Information
    • 11.10.2 Deymed Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.10.3 Deymed Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Deymed Main Business Overview
    • 11.10.5 Deymed Latest Developments
  • 11.11 Mindful Health Solutions
    • 11.11.1 Mindful Health Solutions Company Information
    • 11.11.2 Mindful Health Solutions Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.11.3 Mindful Health Solutions Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Mindful Health Solutions Main Business Overview
    • 11.11.5 Mindful Health Solutions Latest Developments
  • 11.12 RUSH
    • 11.12.1 RUSH Company Information
    • 11.12.2 RUSH Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.12.3 RUSH Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 RUSH Main Business Overview
    • 11.12.5 RUSH Latest Developments
  • 11.13 NeuroStim
    • 11.13.1 NeuroStim Company Information
    • 11.13.2 NeuroStim Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.13.3 NeuroStim Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 NeuroStim Main Business Overview
    • 11.13.5 NeuroStim Latest Developments
  • 11.14 Burrell Behavioral Health
    • 11.14.1 Burrell Behavioral Health Company Information
    • 11.14.2 Burrell Behavioral Health Transcranial Magnetic Stimulation Treatment Product Offered
    • 11.14.3 Burrell Behavioral Health Transcranial Magnetic Stimulation Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Burrell Behavioral Health Main Business Overview
    • 11.14.5 Burrell Behavioral Health Latest Developments

12 Research Findings and Conclusion

The global market for Transcranial Magnetic Stimulation Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Transcranial Magnetic Stimulation Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Transcranial Magnetic Stimulation Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Transcranial Magnetic Stimulation Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Transcranial Magnetic Stimulation Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Transcranial Magnetic Stimulation Treatment players cover Mindpath Health, Neuronetics, Smart rTMS Limited, Magstim and MagVenture, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Transcranial Magnetic Stimulation Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Transcranial Magnetic Stimulation Treatment market, with both quantitative and qualitative data, to help readers understand how the Transcranial Magnetic Stimulation Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Transcranial Magnetic Stimulation Treatment market and forecasts the market size by Type (Deep Transcranial Magnetic Stimulation Treatment and General Transcranial Magnetic Stimulation Treatment,), by Application (Depression, Anxiety Disorder, Obsessive-compulsive Disorder and Smoking Addiction), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Deep Transcranial Magnetic Stimulation Treatment
General Transcranial Magnetic Stimulation Treatment

Segmentation by application
Depression
Anxiety Disorder
Obsessive-compulsive Disorder
Smoking Addiction
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Mindpath Health
Neuronetics
Smart rTMS Limited
Magstim
MagVenture
NeuroStar
Nexstim
Neurocare
Awakenings KC
Deymed
Mindful Health Solutions
RUSH
NeuroStim
Burrell Behavioral Health

Chapter Introduction
Chapter 1: Scope of Transcranial Magnetic Stimulation Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Transcranial Magnetic Stimulation Treatment market size and CAGR, Transcranial Magnetic Stimulation Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transcranial Magnetic Stimulation Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transcranial Magnetic Stimulation Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transcranial Magnetic Stimulation Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Mindpath Health, Neuronetics, Smart rTMS Limited, Magstim, MagVenture, NeuroStar, Nexstim, Neurocare and Awakenings KC, etc.
Chapter 14: Research Findings and Conclusion
Buy now